Reconstruction for Symptomatic Vertebral Artery Lesion Using Vertebral Artery to Carotid Artery Transposition: A Retrospective Study.


Journal

Annals of vascular surgery
ISSN: 1615-5947
Titre abrégé: Ann Vasc Surg
Pays: Netherlands
ID NLM: 8703941

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 20 11 2021
revised: 11 01 2022
accepted: 23 01 2022
pubmed: 9 3 2022
medline: 9 9 2022
entrez: 8 3 2022
Statut: ppublish

Résumé

A posterior circulation infarction is caused by a vertebral artery (VA) lesion (stenosis or occlusion). The purpose of this study is to assess early and long-term outcomes after open surgery for a VA lesion at the origin. In a retrospective study conducted from January 1, 2000 through March 31, 2020 in a single center, patients were treated with vertebral artery to carotid artery transposition (VCT). A total of 28 patients, with a mean age of 65.29 ± 9.81 years (range 45-84), were screened, including 22 patients with VA stenosis and 6 patients with VA occlusion. The complication rate was 21.4% (n = 6), including Horner syndrome (n = 2), lymphocele (n = 1), respiratory failure (n = 1), embolism of a subclavian artery stenosis (n = 1), and vocal cord paralysis (n = 1). The 30-day mortality rate was 0%. Primary patency was 100%. Overall, improvement in symptoms was 85.7% (n = 24) after surgery and 96.4% after 30 days. In the long-term results, primary patency was 100%, and the cumulative patency rate after 60 months was 85.7%, with 1 occlusion of the VA. Cumulative survival rates were 94%, 87%, 69%, and 59% after 12, 24, 60, and 72 months (n = 5). One of the 3 patients died after 60 months because of VA occlusion and posterior circulation infarction. VCT is a safe, effective, and durable procedure. It provides good stroke protection, symptomatic relief, and perioperative risk at acceptable levels, in experienced hands.

Sections du résumé

BACKGROUND BACKGROUND
A posterior circulation infarction is caused by a vertebral artery (VA) lesion (stenosis or occlusion). The purpose of this study is to assess early and long-term outcomes after open surgery for a VA lesion at the origin.
METHODS METHODS
In a retrospective study conducted from January 1, 2000 through March 31, 2020 in a single center, patients were treated with vertebral artery to carotid artery transposition (VCT).
RESULTS RESULTS
A total of 28 patients, with a mean age of 65.29 ± 9.81 years (range 45-84), were screened, including 22 patients with VA stenosis and 6 patients with VA occlusion. The complication rate was 21.4% (n = 6), including Horner syndrome (n = 2), lymphocele (n = 1), respiratory failure (n = 1), embolism of a subclavian artery stenosis (n = 1), and vocal cord paralysis (n = 1). The 30-day mortality rate was 0%. Primary patency was 100%. Overall, improvement in symptoms was 85.7% (n = 24) after surgery and 96.4% after 30 days. In the long-term results, primary patency was 100%, and the cumulative patency rate after 60 months was 85.7%, with 1 occlusion of the VA. Cumulative survival rates were 94%, 87%, 69%, and 59% after 12, 24, 60, and 72 months (n = 5). One of the 3 patients died after 60 months because of VA occlusion and posterior circulation infarction.
CONCLUSIONS CONCLUSIONS
VCT is a safe, effective, and durable procedure. It provides good stroke protection, symptomatic relief, and perioperative risk at acceptable levels, in experienced hands.

Identifiants

pubmed: 35257920
pii: S0890-5096(22)00076-0
doi: 10.1016/j.avsg.2022.01.031
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

148-154

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Mansur Duran (M)

Department of Vascular and Endovascular Surgery, Marienhospital Gelsenkirchen, Teaching Hospital University of Duisburg/Essen, Gelsenkirchen, Germany. Electronic address: mansur.duran@hhu.de.

Hubert Schelzig (H)

Department of Vascular and Endovascular Surgery University Hospital of Duesseldorf, Duesseldorf, Germany.

Aleksandar Petrov (A)

Department of Vascular and Endovascular Surgery, Marienhospital Gelsenkirchen, Teaching Hospital University of Duisburg/Essen, Gelsenkirchen, Germany.

Artis Knapsis (A)

Department of Vascular and Endovascular Surgery University Hospital of Duesseldorf, Duesseldorf, Germany.

Markus Krausch (M)

Department of Surgery, Marienhospital Gelsenkirchen, Teaching Hospital University of Duisburg/Essen, Gelsenkirchen, Germany.

Klaus Grabitz (K)

Department of Vascular and Endovascular Surgery University Hospital of Duesseldorf, Duesseldorf, Germany.

Waseem Garabet (W)

Department of Vascular and Endovascular Surgery University Hospital of Duesseldorf, Duesseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH